From: Neck circumference as an independent indicator to non-alcoholic fatty liver disease in non-obese men
Women | Neck circumference (cm) | P | |||
---|---|---|---|---|---|
≤30 | 30–31 | 31–32 | >32 | ||
N | 398 | 463 | 657 | 406 | |
Age (yr) | 48.17 ± 13.97 | 49.81 ± 14.13 | 50.89 ± 13.78 | 52.14 ± 13.40 | <0.01 |
weight (kg) | 50.98 ± 4.66 | 53.81 ± 4.93 | 56.10 ± 5.28 | 56.87 ± 5.44 | <0.01 |
Waist circumference (cm) | 67.65 ± 6.20 | 70.94 ± 5.92 | 73.56 ± 6.18 | 76.32 ± 7.42 | <0.01 |
Hip circumference (cm) | 86.57 ± 4.48 | 88.60 ± 4.28 | 88.67 ± 4.75 | 91.57 ± 4.75 | <0.01 |
Waist to hip ratio | 0.78 ± 0.06 | 0.80 ± 0.07 | 0.81 ± 0.07 | 0.82 ± 0.08 | <0.01 |
BMI (kg/m2) | 21.11 ± 1.62 | 21.96 ± 1.66 | 22.54 ± 1.53 | 22.82 ± 1.68 | <0.01 |
SBP (mmHg) | 121.27 ± 19.90 | 121.87 ± 19.38 | 124.05 ± 20.09 | 128.69 ± 21.74 | <0.01 |
DBP (mmHg) | 72.53 ± 11.22 | 73.15 ± 11.52 | 74.24 ± 12.06 | 75.73 ± 12.75 | <0.01 |
FBG (mmol/L) | 5.30 ± 0.78 | 5.35 ± 1.05 | 5.46 ± 1.01 | 5.66 ± 1.26 | <0.01 |
Fasting insulin (pmol/L) | 27.5(20.5–37.5) | 28.7(21.85–38.15) | 33.3(25.0–47.2) | 35.9(27.6–46.3) | <0.01 |
HbA1c (%) | 5.10 ± 0.59 | 5.15 ± 0.69 | 5.21 ± 0.65 | 5.24 ± 0.95 | <0.01 |
HOMA-IR | 0.92(0.65–1.27) | 0.97(0.69–1.32) | 1.18(0.84–1.56) | 1.25(0.88–1.80) | <0.01 |
Total cholerterol (mmol/L) | 4.89 ± 0.96 | 5.00 ± 1.05 | 4.96 ± 1.03 | 4.98 ± 0.98 | 0.42 |
LDL-cholesterol (mmol/L) | 2.75 ± 0.70 | 2.88 ± 0.72 | 2.84 ± 0.71 | 2.80 ± 0.68 | 0.03 |
HDL-cholesterol (mmol/L) | 1.63 ± 0.31 | 1.59 ± 0.30 | 1.52 ± 0.30 | 1.46 ± 0.30 | <0.01 |
Triglycerides (mmol/L) | 1.02(0.75–1.36) | 1.03(0.77–1.49) | 1.11(0.84–1.56) | 1.25(0.88–1.80) | <0.01 |
Creatinine (umol/L) | 68.83 ± 9.63 | 69.50 ± 9.82 | 69.25 ± 10.68 | 67.25 ± 14.73 | 0.03 |
eGFR (ml/min/1.732) | 89.73 ± 15.36 | 88.17 ± 15.52 | 89.14 ± 16.64 | 92.181 ± 19.12 | <0.05 |
ALT (U/L) | 14(11–19) | 14(11–19) | 15(12–21) | 16(13–22) | <0.01 |
AST (U/L) | 21(18–25) | 21(18–26) | 21(18–26) | 21(19–25) | 0.17 |
NAFLD,% | 3.02 % | 5.39 % | 8.52 % | 12.56 % | <0.05 |